← Back to patent-cliff list
CAS 1916469-83-4
(7S)-7-Hydroxy-7-methyl-1,4-dioxaspiro[4.5]decan-8-one
Codes：(XV)101438-57-b
Application context (from source-drug indications)
乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(±)-7-Methyl-1,4-dioxaspiro[4.5]decane-7,8-diol→(4S)-4-(Benzyloxy)-3-methylcyclohex-2-en-1-one→(+)-(7S,8R)-7-Hydroxy-7-methyl-1,4-dioxaspiro[4.5]decan-8-yl dodecanoate→(+)-(7S,8R)-7-Methyl-1,4-dioxaspiro[4.5]decane-7,8-diol→(7S)-7-Hydroxy-7-methyl-1,4-dioxaspiro[4.5]decan-8-one→(7S,8S)-7-Methyl-1,4-dioxaspiro[4.5]decane-7,8-diol→(7S,8S)-8-(Benzyloxy)-7-methyl-1,4-dioxaspiro[4.5]decan-7-ol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.